|
Market Closed -
Nasdaq Stockholm
13:00:00 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.5150 SEK | -0.96% |
|
-0.58% | -83.98% |
| 10-12 | Redeye sees potential path forward for Ascelia after FDA update | FW |
| 10-12 | Ascelia Pharma AB - Special Call |
Chart: Technical Analysis
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ACE | Delayed | |
CBOE
| ACEs | Real-time | |
|
CBOE
| Real-time | ||
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| 7ZA | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.658 | 1.248 | 1.266 |
| Spread/Res. | -21.73% | -58.74% | -59.32% |
| Spread/Supp. | +1.78% | +8.42% | +5.10% |
| Support | 0.506 | 0.475 | 0.49 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ACE Stock
- Charts Ascelia Pharma AB
Select your edition
All financial news and data tailored to specific country editions
